Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Danish Down's study recommends changes

This article was originally published in Clinica

Executive Summary

Denmark could succeed in cutting the number of children born with Down's syndrome from an average of 65 to 15 per year if current guidelines were revised to introduce serum screening and nuchal translucency ultrasound. A recent study on screening for Down's syndrome in Denmark 1980-98 claims that current screening methods based on age as a basis for invasive prenatal diagnostics mean that for every case avoided, two healthy foetuses are aborted. This is because invasive techniques, in this case chorionic villus sampling (CVS) and amniocentesis (AC), carry an inherent risk of a 1% spontaneous abortion rate, says the report.

Topics

UsernamePublicRestriction

Register

MT068357

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel